Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBT Margin (2016 - 2025)

Mesa Laboratories' EBT Margin history spans 16 years, with the latest figure at 7.58% for Q4 2025.

  • For Q4 2025, EBT Margin rose 1111.0% year-over-year to 7.58%; the TTM value through Dec 2025 reached 5.77%, up 11926.0%, while the annual FY2025 figure was 2.47%, 12998.0% up from the prior year.
  • EBT Margin for Q4 2025 was 7.58% at Mesa Laboratories, up from 3.07% in the prior quarter.
  • Across five years, EBT Margin topped out at 12.89% in Q1 2021 and bottomed at 467.42% in Q1 2024.
  • The 5-year median for EBT Margin is 3.3% (2022), against an average of 20.59%.
  • The largest annual shift saw EBT Margin plummeted -46693bps in 2024 before it surged 46817bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 4.28% in 2021, then soared by 182bps to 3.53% in 2022, then increased by 3bps to 3.64% in 2023, then crashed by -197bps to 3.53% in 2024, then soared by 315bps to 7.58% in 2025.
  • Per Business Quant, the three most recent readings for MLAB's EBT Margin are 7.58% (Q4 2025), 3.07% (Q3 2025), and 11.78% (Q2 2025).